Monday, June 15, 2026

Samsung’s AI-Driven Appliances at AWE 2025—Better Cooling, Smarter Washing

Samsung Electronics showcases AI-powered home appliances at AWE 2025, enhancing local lifestyles with innovative tech and energy efficiency.

North Korea’s ‘Southern Border Line’ Push Shakes Armistice Framework, Raises Need for New Coexistence Approach

North Korea's shift to define the MDL as a "southern border line" poses threats but also opportunities for new coexistence strategies.

Tesla’s Rough Patch: Profit and Revenue Expected to Fall

Ahead of Tesla's earnings announcement on the...

Tag: Neok Bio

ABL Bio to Invest Additional $25 Million in Neok Bio to Accelerate ADC Clinical Trials

ABL Bio invests $25M in Neok Bio for bispecific antibody-drug conjugate trials, aiming for FDA-approved treatments by 2027.

Unlocking Cancer Treatment: ABL206 and ABL209’s Promising Non-Clinical Data Revealed at AACR

ABL Bio will present preclinical data for its ADCs ABL206 and ABL209 at AACR 2023, showcasing promising anti-cancer efficacy.

ABL206: First-in-Class Dual Antibody Drug Conjugate Approved for Clinical Trials in the U.S. – What This Means for Cancer Treatment

ABL Bio and Neok Bio received FDA approval for ABL206, a dual-antibody ADC, marking a key milestone in their clinical development efforts.

Top News

- Our Sponsors Ad -

Follow us